Doesn't it all come down to this , it's why I've come back on board,
Looking odds-on favourite to me that we will significantly outperform incumbents and set a new standard of care for canine lymphoma.
USD $19M = AUD $30M up front payment for Laverdia, more than our current MC.
Total Deal for Laverdia USD $64M = AUD $100M ... given our performance maybe total deal $150M on delivery of successful phase 3.
Fundamentally re-rates PAA.
I understand the frustration of LTH's, but I've been back on board for 8 weeks and I'm bloody excited !!
Ann: AGM Presentation, page-9
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |